FURIN and COVID-19: In addition, furin inhibitors are capable of suppressing cleavage of spike (S) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the S1/S2 site, thus making furin an attractive target for therapeutic intervention in acute respiratory tract infection, COVID-19.